We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4,690.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2019 to Apr 2024
TIDMSHP
RNS Number : 6952L
JPMorgan Securities Plc
20 April 2018
AMMENT
INCREASED EQUITY PURCHASES BY 5,700 TO 435,386
ADDED EQUITY SWAP SALES OF 5,700
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Name of exempt principal trader: J.P. Morgan Securities Plc ---------------------------------------------------------- ---------------------------------------------------------- (b) Name of offeror/offeree in relation to whose relevant Shire plc securities this form relates: Use a separate form for each offeror/offeree ---------------------------------------------------------- ---------------------------------------------------------- (c) Name of the party to the offer with which exempt Joint Financial Adviser to Takeda Pharmaceutical Company principal trader is connected: Limited ---------------------------------------------------------- ---------------------------------------------------------- (d) Date dealing undertaken: 13 April 2018 ---------------------------------------------------------- ---------------------------------------------------------- (e) In addition to the company in 1(b) above, is the Yes, Takeda Pharmaceutical Company Limited exempt principal trader making disclosures in respect of any other party to this offer? If it is a cash offer or possible cash offer, state "N/A" ---------------------------------------------------------- ---------------------------------------------------------- 2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
Hot Features
Premium
(a) Purchases and sales
Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
(GBP) (GBP)
----------------------- ----------------- ------------------------ ----------------------- -----------------------
Ordinary Shares Purchases 435,386 37.2166 35.7000
Sales 391,644 37.2150 35.7400
----------------------- ----------------- ------------------------ ----------------------- -----------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities (GBP)
long/short position,
increasing/reducing a
long/short position
------------------------- -------------------- ------------------------- ------------------------- ---------------
Ordinary Shares Equity Swaps Long 42,087 36.0634
531 36.0650
1,180 36.1417
1,184 36.2245
16,045 36.2506
18 36.4526
4,116 36.6457
8,357 36.6532
45,640 36.7031
6,797 36.7303
141 36.7712
3,386 36.8833
4,924 36.8906
919 36.9253
120 37.0420
Short 32 35.9661
68 36.0011
1,319 36.0247
309 36.0512
1,606 36.0650
655 36.1128
33 36.1144
429 36.1434
3,812 36.2370
801 36.2508
15,164 36.3029
5,700 36.3399
919 36.3647
13,202 36.4000
4,559 36.4022
61,013 36.4272
207 36.4530
2,910 36.4652
36,126 36.4729
15,476 36.5003
1,550 36.6669
116 36.6968
8,344 37.0470
616 37.2166
------------------------- -------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option (GBP) European unit
relates etc. (GBP)
------------- ------------- ------------- ------------- -------------- ------------- ------------ -------------
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
(GBP)
----------------------- -------------------- ----------------------- --------------------- -----------------------
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable) (GBP)
e.g. subscription, conversion
--------------------------- ------------------------------- -------- -------------------------------------
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" ---------------------------------------------------------------------------------------------- None ---------------------------------------------------------------------------------------------- (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" ----------------------------------------------------------------------------------------------- None ----------------------------------------------------------------------------------------------- Date of disclosure: 20 April 2018 --------------------- -------------- Contact name: Alwyn Basch --------------------- -------------- Telephone number: 020 7742 7407 --------------------- --------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS
The company news service from the London Stock Exchange
END
FERLLFFDSSIIFIT
(END) Dow Jones Newswires
April 20, 2018 13:26 ET (17:26 GMT)
1 Year Shire Chart |
1 Month Shire Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
